Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2019 Oct 9;20(1):e30–e37. doi: 10.1016/j.clml.2019.09.622

Figure 1.

Figure 1.

Study selection flowchart. Results of literature search using PubMed and manual searches of the American Society of Hematology and the European Hematology Association annual meeting abstracts are shown. Additional data were included from the CLARION study.

ALL, acute lymphoblastic leukemia; MRD, minimal residual disease.